Walleye Capital’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,400
Closed -$1.57M 4489
2025
Q4
$1.57M Sell
48,400
-14,600
-23% -$456K ﹤0.01% 2058
2025
Q3
$1.78M Buy
63,000
+2,700
+4% +$77.5K 0.01% 1659
2025
Q2
$1.82M Buy
60,300
+46,300
+331% +$1.57M 0.01% 1590
2025
Q1
$573K Buy
+14,000
New +$673K ﹤0.01% 2437
2024
Q4
Sell
-18,800
Closed -$1.22M 4949
2024
Q3
$1.22M Buy
18,800
+12,700
+208% +$816K ﹤0.01% 2433
2024
Q2
$378K Buy
6,100
+300
+5% +$20.8K ﹤0.01% 3755
2024
Q1
$491K Buy
5,800
+3,300
+132% +$262K ﹤0.01% 3214
2023
Q4
$187K Buy
+2,500
New +$174K ﹤0.01% 3714
2019
Q4
Sell
-800
Closed -$73K 1865
2019
Q3
$73K Buy
+800
New +$72.9K ﹤0.01% 1505

Other funds holding CRI

Walleye Capital's CRI Position: Q1 2026 in Review

Walleye Capital sold out of Carter's (CRI) in Q1 2026, closing a stake of 3,015 shares — an estimated $97.8K sold.

Walleye Capital first reported a position in CRI in Q1 2021 and held it in 14 quarters. The position peaked at $22M in Q4 2024. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • Walleye Capital reported no remaining Carter's position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 3,015 Carter's shares in Q1 2026, an estimated $97.8K.
  • Walleye Capital first reported a position in Carter's in Q1 2021 and held it in 14 quarters.
  • Walleye Capital's Carter's position peaked at $22M in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.